2112, 2023 Prometheus Laboratories Announces a Major Milestone in Demonstrating Clinical Utility of Precision-Guided Dosing for Optimizing IBD Patient Care and Cost SavingsKen Chueh2023-12-21T06:05:00-08:002023-12-21| News & Events Prometheus [...]Read More
2908, 2023 Prometheus Laboratories Surpasses 35 Million Covered Lives Under Positive Medical Policy for Anser® Therapeutic Drug MonitoringKen Chueh2024-03-13T11:47:03-07:002023-08-29| News & Events Prometheus [...]Read More
108, 2023 Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser® TestingKen Chueh2024-03-13T11:46:12-07:002023-08-01| News & Events Prometheus [...]Read More
2707, 2023 Prometheus Laboratories Announces the Launch of PredictrPK® ADA, A Precision-Guided Dosing Test for Optimization of AdalimumabKen Chueh2023-07-26T15:59:06-07:002023-07-27| News & Events Prometheus [...]Read More
205, 2023 Lynx.MD Partners with Prometheus Laboratories and Gastro Health to Leverage Medical Data Intelligence Platform for Inflammatory Bowel Disease ResearchKen Chueh2023-07-18T16:09:33-07:002023-05-02| News & Events Lynx.MD [...]Read More
203, 2023 Prometheus Launches New Indication for PredictrPK® IFX, A Precision-Guided Dosing Test for IBDNicole Drago2023-04-12T22:31:38-07:002023-03-02| News & Events [...]Read More